accordingly , 39 seated patients received under the same conditions both saralasin , an octapeptide competitive antagonist of angiotensin ii , and the nonapeptide converting enzyme inhibitor , sq20881 , which blocks the generation of angiotensin ii from angiotensin i .
C0036193
saralasin
C0003009
angiotensin ii